Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

UNIVERSITY OF WASHINGTON

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1861-01-01

Employees: 10K

Market Cap: -

Website: https://www.cs.washington.edu

Clinical Trials

ACY-6 Oral Administration of Acyline

Phase 1

Completed

Conditions: Contraception

Interventions: Drug: Acyline

First Posted Date: 2007-05-09

Last Posted Date: 2010-12-03

Lead Sponsor: University of Washington

Target Recruit Count: 9

Registration Number: NCT00471185

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

62% & 15% Ethanol in Emollient Gel as Topical Male Microbicides

Phase 1

Completed

Conditions: Sexually Transmitted Infections

Interventions: Other: 62% ethanol in emollient gel
Drug: Placebo
Other: 15% ethanol in emollient gel

First Posted Date: 2007-05-04

Last Posted Date: 2009-04-30

Lead Sponsor: University of Washington

Target Recruit Count: 30

Registration Number: NCT00469547

Locations: 🇰🇪
Kenya Medical Research Institute, Kisumu, Kenya

Nurse-led Case Management for Diabetes and Cardiovascular Disease Patients With Depression

Not Applicable

Completed

Conditions: Depression

Interventions: Behavioral: Treatment as usual
Behavioral: Nurse-led case management

First Posted Date: 2007-05-03

Last Posted Date: 2014-05-02

Lead Sponsor: University of Washington

Target Recruit Count: 214

Registration Number: NCT00468676

Locations: 🇺🇸
Group Health Cooperative, Seattle, Washington, United States

Sorafenib Tosylate and Gene Expression Analysis in Patients Undergoing Surgery For High-Risk Localized Prostate Cancer

Phase 2

Completed

Conditions: Stage II Prostate Cancer
Adenocarcinoma of the Prostate
Stage III Prostate Cancer

Interventions: Drug: sorafenib tosylate
Genetic: microarray analysis
Other: immunohistochemistry staining method
Genetic: gene expression analysis
Procedure: needle biopsy
Procedure: therapeutic conventional surgery
Other: laboratory biomarker analysis
Genetic: western blotting
Genetic: RNA analysis

First Posted Date: 2007-04-27

Last Posted Date: 2017-11-22

Lead Sponsor: University of Washington

Target Recruit Count: 5

Registration Number: NCT00466752

Locations: 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States

Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy

Phase 2

Completed

Conditions: Ovarian Clear Cell Cystadenocarcinoma
Stage IV Ovarian Epithelial Cancer
Ovarian Endometrioid Adenocarcinoma
Peritoneal Cavity Cancer
Ovarian Serous Cystadenocarcinoma
Ovarian Undifferentiated Adenocarcinoma
Brenner Tumor
Fallopian Tube Cancer
Ovarian Mixed Epithelial Carcinoma
Ovarian Mucinous Cystadenocarcinoma

Interventions: Biological: sargramostim
Drug: paclitaxel albumin-stabilized nanoparticle formulation
Other: laboratory biomarker analysis
Other: immunologic technique

First Posted Date: 2007-04-27

Last Posted Date: 2017-08-28

Lead Sponsor: University of Washington

Target Recruit Count: 21

Registration Number: NCT00466960

Locations: 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States

HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1 Co-infected Persons

Phase 3

Completed

Conditions: HIV Infections
Herpes Simplex
Sexually Transmitted Diseases

Interventions: Drug: Valacyclovir
Drug: Matching Placebo

First Posted Date: 2007-04-24

Last Posted Date: 2013-08-22

Lead Sponsor: University of Washington

Target Recruit Count: 20

Registration Number: NCT00465205

Locations: 🇵🇪
Asociacion Civil Impacta Salud y Educacion, Lima, Peru

High-Risk HPV Infections in Women Aged 25 to 65

Completed

Conditions: Papillomavirus Infections

First Posted Date: 2007-04-18

Last Posted Date: 2013-11-19

Lead Sponsor: University of Washington

Target Recruit Count: 303

Registration Number: NCT00461877

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

PEARL Intervention to Reduce Depression Among Adults With Epilepsy

Not Applicable

Conditions: Depression
Epilepsy

First Posted Date: 2007-04-11

Last Posted Date: 2008-06-04

Lead Sponsor: University of Washington

Target Recruit Count: 80

Registration Number: NCT00459329

Locations: 🇺🇸
Regional Epilepsy Center, Harborview Medical Center, Seattle, Washington, United States

Identifying Genes That Predict Risk of Developing Cervical Intraepithelial Neoplasia or Invasive Cervical Cancer

Completed

Conditions: Cervical Cancer
Precancerous Condition

First Posted Date: 2007-04-11

Last Posted Date: 2013-11-19

Lead Sponsor: University of Washington

Target Recruit Count: 1680

Registration Number: NCT00458562

Locations: 🇸🇳
Centre Hospitalier Universite De Fann, Dakar, Senegal
🇸🇳
Hopital Aristide Le Dantec, Dakar, Senegal

Marketing Workplace Chronic Disease Prevention

Not Applicable

Completed

Conditions: Health Behavior
Chronic Disease

Interventions: Behavioral: Workplace Solutions Consulting approach
Behavioral: Delayed intervention

First Posted Date: 2007-03-28

Last Posted Date: 2009-11-20

Lead Sponsor: University of Washington

Target Recruit Count: 48

Registration Number: NCT00452816

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy